JW Pharmaceutical Posts 93.6 Billion Won Operating Profit Last Year, Up 13.5% Year-on-Year
JW Pharmaceutical announced in a regulatory filing on February 2 that its provisional operating profit for last year reached 93.63 billion won, a 13.5% increase compared to the previous year's operating profit of 82.49 billion won.
During the same period, sales amounted to 774.8 billion won, up 7.7% from 719.38 billion won in the previous year, while net profit for the year decreased by 5.15% to 61.69 billion won.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The company explained that the main factors behind the changes in its profit structure, including operating profit, were increased sales driven by focused development of key products such as Livaro and Livarozet, and a decrease in net profit for the year due to additional corporate tax payments.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.